Tag: venture capital
-
All the Ways Elon Inc. Is Already Intertwined: Beyond the Merger Talk
Introduction: A Growing Web of Interconnections Elon Musk’s portfolio reads like a map of the modern tech and transportation frontier. From electric cars to rockets, neural interfaces to underground transit, the enterprises associated with Elon Inc. are more than standalone ventures. They are a tightly knit ecosystem where supply chains, partnerships, and even R&D ambitions…
-
Invenio Imaging Appoints Adrian Whitford as Board Director; Welcomes Biao He and John Seamans
Invenio Imaging Strengthens Board with Experienced Technology Leaders Invenio Imaging, a pioneer in fresh tissue imaging and AI-enabled diagnostics, today announced strategic additions to its governing body. Adrian Whitford has been appointed as an Independent Board Director, while Biao He of Oak BioCapital and John Seamans of the Michigan Biomedical Venture Fund join the board.…
-
Waabi Robotaxi Fleet Launch with Uber After $750M Funding
Waabi Announces ambitious robotaxi fleet with Uber Autonomous vehicle developer Waabi Innovation Inc., a Toronto-based startup, has announced a landmark partnership with Uber Technologies Inc. to launch a large-scale robotaxi fleet. The announcement follows Waabi’s completion of a $750 million funding round, one of the most significant venture-capital investments in Canadian history. The collaboration places…
-
Waabi and Uber to Launch Robotaxi Fleet After $750M Raise
Overview: A bold leap in autonomous mobility Canada’s Waabi Innovation Inc. has secured a landmark $750 million investment and announced a strategic partnership with Uber Technologies Inc. to launch a large-scale robotaxi fleet. This collaboration aims to accelerate the deployment of autonomous ridesharing services, marking one of the most significant venture capital milestones in Canadian…
-
Waabi and Uber Launch Robotaxi Fleet After $750M Funding
Waabi secures major funding and announces a bold robotaxi plan Autonomous vehicle startup Waabi Innovation Inc. has secured $750 million in a major round of venture capital financing, positioning the Toronto-based company to accelerate its roadmap for self-driving technology. In a strategic move that could reshape urban mobility, Waabi also revealed plans to deploy a…
-
The Year of the Hectocorn: Which $100bn Tech IPOs Could Float in 2026
What is a hectocorn? The term “hectocorn” is gaining traction as a playful label for tech companies valued at or above $100 billion. Building on the familiar “unicorn” idea, hectocorns represent a rare tier of market capitalization that promises to reshape industry landscapes and investor expectations. As more startups mature into large, diversified platforms with…
-
Ben Horowitz: AI Is Bigger Than the Internet, and What That Means for Startups
AI’s Magnitude: Beyond the Internet Boom Ben Horowitz, the cofounder of Andreessen Horowitz (a16z), has framed the current AI surge as a turning point that could eclipse the internet’s early days in terms of impact, speed, and scope. In recent discussions and interviews, Horowitz has argued that the debate over whether AI is a bubble…
-
Ben Horowitz Says AI Is Bigger Than the Internet: Why the AI Boom Is Real
AI’s Moment Is Bigger Than the Internet’s Arrival When a founder and longtime investor declares that a technology’s impact will exceed the scale of the internet, it’s worth listening. Ben Horowitz, cofounder of Andreessen Horowitz (a16z), recently argued that the current AI surge is not just a headline trend but a fundamental reshaping of business,…
-
Ben Horowitz: AI Is Bigger Than the Internet — What It Means for Startups
AI’s Ascendancy: A New Era Beyond the Internet Tech visionary Ben Horowitz, cofounder of Andreessen Horowitz (a16z), has drawn a bold line between the current AI surge and the early days of the internet. In a recent discussion on The A16z Show, Horowitz argued that the debate over whether the AI boom is a bubble…
-
Arkin Bio Ventures III: Arkin Capital launches a $100M fund for early clinical biotech
Arkin Capital doubles down on early clinical science Arkin Capital has unveiled Arkin Bio Ventures III, a new $100 million biotech fund dedicated to advancing early-stage clinical science. In a landscape that increasingly prizes AI-driven drug discovery, Arkin’s strategy centers on the highest-impact, patient-centered stages of development: the first-in-human and early clinical readouts that can…